Ana T. Duggan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ana T. Duggan has a total of 422 co-authors. Here are the top co-authors by number of shared publications:
- Hendrik N. Poinar
McMaster Ancient DNA Centre, Department of Anthropology, McMaster University, Hamilton, Canada
14 shared publications Melanie Kuch
7 shared publications- Edward Charles Holmes
School of Medical Sciences, The University of Sydney, Sydney, Australia
6 shared publications G. Brian Golding
Department of Biology, McMaster University, Hamilton, ON, L8S 4L8, Canada
5 shared publications- Jennifer Klunk
McMaster Ancient DNA Centre, Departments of Anthropology, Biology and Biochemistry, McMaster University, Hamilton, Canada
5 shared publications John Southon
Keck Carbon Cycle Accelerator Mass Spectrometry Laboratory, Earth Systems Science Department, University of California Irvine, Irvine, California, United States of America
5 shared publications
Latest Publications
- Open Access
Evaluation of MeaSeq: comprehensive analysis and reporting of measles virus whole genome sequences
Although vaccine-preventable, measles virus (MeV) continues to pose a significant public health challenge, with a substantial resurgence of cases worldwide. As whole-genome sequencing (WGS) becomes increasingly affordable and routinely adopted in public health laboratories, reliable and accessible analysis of next-generation sequencing (NGS) data is critical for outbreak investigation and molecular surveillance. Here, we present MeaSeq, a fast, user-friendly, open-source bioinformatics pipeline for MeV analysis using Illumina or Oxford Nanopore Technologies (ONT) NGS data. MeaSeq performs quality control assessments, consensus genome assembly and variant detection, optional genotype-specific reference selection, Distinct Sequence Identifier (DSId) assignment via user-provided databases or hashing, sub-consensus variant visualization, genome quality assessment, and standardized HTML reporting. We compared the performance of MeaSeq on NGS data generated from multiple sequencing platforms and targeted enrichment strategies against gold-standard Sanger data, reference genomes, and publicly available comparative data. This validation demonstrates that MeaSeq provides an accurate, reproducible, and accessible solution for routine MeV WGS analysis, supporting genomic surveillance and outbreak response workflows in public health and research settings. Impact Statement: The recent surge in measles cases worldwide, causing several countries to lose their measles elimination status, underscores the urgent need for effective and accessible genomic surveillance. Our manuscript introduces MeaSeq, a comprehensive and open-source bioinformatics pipeline specifically designed for analyzing MeV NGS data. MeaSeq includes MeV specific analyses such as genotype prediction from sequencing reads with optional genotype-specific reference selection; DSId assignment; quality control checks such as genome rule-of-six divisibility and gene CDS validation; subconsensus nucleotide analysis with mixed-site highlighting; and genomic plotting. By leveraging NGS technology, our pipeline can facilitate the identification of transmission chains and may provide critical insights into the dynamics of MeV outbreaks. This information is essential for public health officials and researchers to implement targeted interventions and optimize vaccine strategies. Additionally, the open-source nature of MeaSeq fosters collaboration and innovation within the scientific measles community along with providing access to a wider range of researchers. Data Summary: The MeaSeq pipeline code is available on GitHub ( https://github.com/phac-nml/measeq ). Comparative datasets of publicly available WGS data were accessed through the NCBI Sequence Read Archive under the following BioProjects: PRJNA869081 ( https://www.ncbi.nlm.nih.gov/bioproject/PRJNA869081 ) PRJNA480551 ( https://www.ncbi.nlm.nih.gov/bioproject/PRJNA480551 ) PRJNA1017431 ( https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1017431 ) PRJNA1241325 ( https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1241325 ) PRJNA1174053 ( https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1174053 ) PRJNA1293457 ( https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1293457 ) PRJNA843031 ( https://www.ncbi.nlm.nih.gov/bioproject/PRJNA843031 ) Whole-genome sequences were included in the validation analysis if they consisted of paired-end data (Illumina) and achieved ≥95% genome completeness following trimming of the 5′ and 3′ untranslated regions (UTRs). This criterion ensured sufficient genome coverage for robust validation while allowing for limited missing data arising from regions of low sequencing depth or amplicon dropout. A complete list of sequences included in the validation, along with their accession numbers, is provided in Supplementary Table 1.
Open AccessEvaluation of MeaSeq: comprehensive analysis and reporting of measles virus whole genome sequences
Although vaccine-preventable, measles virus (MeV) continues to pose a significant public health challenge, with a substantial resurgence of cases worldwide. As whole-genome sequencing (WGS) becomes increasingly affordable and routinely adopted in public health laboratories, reliable and accessible analysis of next-generation sequencing (NGS) data is critical for outbreak investigation and molecular surveillance. Here, we present MeaSeq, a fast, user-friendly, open-source bioinformatics pipeline for MeV analysis using Illumina or Oxford Nanopore Technologies (ONT) NGS data. MeaSeq performs quality control assessments, consensus genome assembly and variant detection, optional genotype-specific reference selection, Distinct Sequence Identifier (DSId) assignment via user-provided databases or hashing, sub-consensus variant visualization, genome quality assessment, and standardized HTML reporting. We compared the performance of MeaSeq on NGS data generated from multiple sequencing platforms and targeted enrichment strategies against gold-standard Sanger data, reference genomes, and publicly available comparative data. This validation demonstrates that MeaSeq provides an accurate, reproducible, and accessible solution for routine MeV WGS analysis, supporting genomic surveillance and outbreak response workflows in public health and research settings. Impact Statement: The recent surge in measles cases worldwide, causing several countries to lose their measles elimination status, underscores the urgent need for effective and accessible genomic surveillance. Our manuscript introduces MeaSeq, a comprehensive and open-source bioinformatics pipeline specifically designed for analyzing MeV NGS data. MeaSeq includes MeV specific analyses such as genotype prediction from sequencing reads with optional genotype-specific reference selection; DSId assignment; quality control checks such as genome rule-of-six divisibility and gene CDS validation; subconsensus nucleotide analysis with mixed-site highlighting; and genomic plotting. By leveraging NGS technology, our pipeline can facilitate the identification of transmission chains and may provide critical insights into the dynamics of MeV outbreaks. This information is essential for public health officials and researchers to implement targeted interventions and optimize vaccine strategies. Additionally, the open-source nature of MeaSeq fosters collaboration and innovation within the scientific measles community along with providing access to a wider range of researchers. Data Summary: The MeaSeq pipeline code is available on GitHub ( https://github.com/phac-nml/measeq ). Comparative datasets of publicly available WGS data were accessed through the NCBI Sequence Read Archive under the following BioProjects: PRJNA869081 ( https://www.ncbi.nlm.nih.gov/bioproject/PRJNA869081 ) PRJNA480551 ( https://www.ncbi.nlm.nih.gov/bioproject/PRJNA480551 ) PRJNA1017431 ( https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1017431 ) PRJNA1241325 ( https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1241325 ) PRJNA1174053 ( https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1174053 ) PRJNA1293457 ( https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1293457 ) PRJNA843031 ( https://www.ncbi.nlm.nih.gov/bioproject/PRJNA843031 ) Whole-genome sequences were included in the validation analysis if they consisted of paired-end data (Illumina) and achieved ≥95% genome completeness following trimming of the 5′ and 3′ untranslated regions (UTRs). This criterion ensured sufficient genome coverage for robust validation while allowing for limited missing data arising from regions of low sequencing depth or amplicon dropout. A complete list of sequences included in the validation, along with their accession numbers, is provided in Supplementary Table 1.
- Open Access
- 29 January 2026
- Published by Microbiology Society in Microbial Genomics
- Vol. 12 (1)
The Mpox contextual data specification package: a data curation toolkit to support collaborative pathogen genomic surveillance
A sudden increase in the number of Mpox virus (MPXV) cases worldwide prompted the WHO to declare a Public Health Emergency of International Concern in 2022 and again in 2024. Public health genomic surveillance of MPXV in impacted areas is ongoing to inform national and international situational awareness, with a growing number of sequences available in public sequence repositories. Critical to genomic surveillance is well-curated and harmonized contextual data – the sample metadata, epidemiological and clinical data, lab results and method information that enables the interpretation of sequence data for public health responses and decision-making. Contextual data, however, is often unstructured or highly variable in formats, granularity and terminology. This variability usually requires a great deal of manual clean-up before it can be integrated and used for analysis, which can be laborious, time-consuming and error-prone. To facilitate harmonization of contextual data for genomic surveillance during the 2022 and 2024 epidemics, an MPXV contextual data specification was developed by the Centre for Infectious Disease Genomics and One Health (Simon Fraser University, Canada) in collaboration with several teams at Canada’s National Microbiology Lab [Public Health Agency of Canada (PHAC)] as well as provincial public health laboratories. The MPXV specification provides standardized ontology-based fields and terms for capturing information about MPXV samples and infections and prioritizes geo-temporal, data provenance and sampling strategy information for surveillance. The specification utilizes the same semantic framework used to develop other public health pathogen genomics data standards, thus demonstrating its adaptability for additional infectious diseases. The specification has been implemented as a template within an open-source application known as the DataHarmonizer, which provides curation, validation and data transformation features and functions. The MPXV specification is already being utilized in Canada and is freely available for international use. The MPXV specification adds to a growing library of interoperable, harmonized community consensus contextual data standards for public health pathogen genomics.
- 29 January 2026
- Published by Microbiology Society in Microbial Genomics
- Vol. 12 (1)
Open AccessThe Mpox contextual data specification package: a data curation toolkit to support collaborative pathogen genomic surveillance
A sudden increase in the number of Mpox virus (MPXV) cases worldwide prompted the WHO to declare a Public Health Emergency of International Concern in 2022 and again in 2024. Public health genomic surveillance of MPXV in impacted areas is ongoing to inform national and international situational awareness, with a growing number of sequences available in public sequence repositories. Critical to genomic surveillance is well-curated and harmonized contextual data – the sample metadata, epidemiological and clinical data, lab results and method information that enables the interpretation of sequence data for public health responses and decision-making. Contextual data, however, is often unstructured or highly variable in formats, granularity and terminology. This variability usually requires a great deal of manual clean-up before it can be integrated and used for analysis, which can be laborious, time-consuming and error-prone. To facilitate harmonization of contextual data for genomic surveillance during the 2022 and 2024 epidemics, an MPXV contextual data specification was developed by the Centre for Infectious Disease Genomics and One Health (Simon Fraser University, Canada) in collaboration with several teams at Canada’s National Microbiology Lab [Public Health Agency of Canada (PHAC)] as well as provincial public health laboratories. The MPXV specification provides standardized ontology-based fields and terms for capturing information about MPXV samples and infections and prioritizes geo-temporal, data provenance and sampling strategy information for surveillance. The specification utilizes the same semantic framework used to develop other public health pathogen genomics data standards, thus demonstrating its adaptability for additional infectious diseases. The specification has been implemented as a template within an open-source application known as the DataHarmonizer, which provides curation, validation and data transformation features and functions. The MPXV specification is already being utilized in Canada and is freely available for international use. The MPXV specification adds to a growing library of interoperable, harmonized community consensus contextual data standards for public health pathogen genomics.
- Open Access
- 27 January 2026
- Published by Microbiology Society in Microbial Genomics
- Vol. 12 (1)
Optimizing data-driven excellence: Canada’s approach to using pathogen test datasets for quality control, pipeline development and training initiatives
Pathogen genomic surveillance is globally recognized as a pillar of public health. This field has expanded rapidly following the onset of the coronavirus disease 2019 (COVID-19) pandemic, and there is an urgent need to ensure the quality, comparability and reliability of the results of genomic analyses across diverse settings and analytical platforms. Currently, no methodology or framework has been universally adopted to mitigate this issue. This study aimed to provide a solution within the Canadian public health landscape by using standardized test datasets for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic analysis. In this context, a test dataset refers to a curated set of genomic sequences designed to evaluate the accuracy, consistency and performance of sequencing workflows, bioinformatics pipelines and analytical tools. These datasets serve as benchmarks, allowing laboratories to validate their methodologies and ensure comparability across different platforms. The test datasets included in this analysis were selected based on the use of well-characterized experimental protocols from the application of specimen selection criteria, through to sequence generation. Datasets generated using Illumina and Nanopore sequencing of samples from COVID-19 patients in Saskatchewan, Canada, were used and included clean controls, variable lineages and spiked-in lower-quality run data. Illumina libraries were sequenced using ARTIC network PCR amplification, while Nanopore libraries underwent similar protocols with some modifications. Public test dataset access on Zenodo further facilitates reproducibility, providing data summary outputs and pipeline environment files. A customized R script was developed to compare Illumina data, generating multiple tables and figures highlighting comparisons between analyses. The significance of this study lies in its contribution to the implementation of bioinformatic pipeline validation tools and protocols, which are essential for reliable genomic surveillance and outbreak response. By establishing a structured framework for computational validation, this study enhances the accuracy, comparability and efficiency of genomic surveillance in an evolving landscape of viral strains and testing strategies.
- 27 January 2026
- Published by Microbiology Society in Microbial Genomics
- Vol. 12 (1)
Open AccessOptimizing data-driven excellence: Canada’s approach to using pathogen test datasets for quality control, pipeline development and training initiatives
Pathogen genomic surveillance is globally recognized as a pillar of public health. This field has expanded rapidly following the onset of the coronavirus disease 2019 (COVID-19) pandemic, and there is an urgent need to ensure the quality, comparability and reliability of the results of genomic analyses across diverse settings and analytical platforms. Currently, no methodology or framework has been universally adopted to mitigate this issue. This study aimed to provide a solution within the Canadian public health landscape by using standardized test datasets for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic analysis. In this context, a test dataset refers to a curated set of genomic sequences designed to evaluate the accuracy, consistency and performance of sequencing workflows, bioinformatics pipelines and analytical tools. These datasets serve as benchmarks, allowing laboratories to validate their methodologies and ensure comparability across different platforms. The test datasets included in this analysis were selected based on the use of well-characterized experimental protocols from the application of specimen selection criteria, through to sequence generation. Datasets generated using Illumina and Nanopore sequencing of samples from COVID-19 patients in Saskatchewan, Canada, were used and included clean controls, variable lineages and spiked-in lower-quality run data. Illumina libraries were sequenced using ARTIC network PCR amplification, while Nanopore libraries underwent similar protocols with some modifications. Public test dataset access on Zenodo further facilitates reproducibility, providing data summary outputs and pipeline environment files. A customized R script was developed to compare Illumina data, generating multiple tables and figures highlighting comparisons between analyses. The significance of this study lies in its contribution to the implementation of bioinformatic pipeline validation tools and protocols, which are essential for reliable genomic surveillance and outbreak response. By establishing a structured framework for computational validation, this study enhances the accuracy, comparability and efficiency of genomic surveillance in an evolving landscape of viral strains and testing strategies.
- Open Access
- 10 December 2025
- Published by Oxford University Press (OUP) in Virus Evolution
- Vol. 12 (1)
Human outbreak detection and best practice MPXV analysis and interpretation with squirrel
High numbers of reported mpox cases and recent identification of multiple sustained human outbreaks of mpox virus (MPXV) have highlighted the need for robust, best-practice genomic surveillance tools. In light of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, many labs across the globe developed the capacity to do virus genome sequencing; however, MPXV presents additional analytical challenges due to its large genome size, tracts of low-complexity or repeat regions, genetically distinct clades, and the need to perform bespoke apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3 (APOBEC3)-mutation reconstruction. We present squirrel (Some Quick Reconstruction to Resolve Evolutionary Links), an open source bioinformatic tool that can perform clade-aware alignment, mutation quality assessment, phylogenetic inference, and automated APOBEC3-mutation classification on branches of the phylogeny. Squirrel can be run on the command line or launched through the EPI2ME graphical user interface through the squirrel-nf workflow, enabling robust analysis without need for the command line. With the interactive output report produced and publication-ready APOBEC3-reconstruction visualization, squirrel enables researchers to distinguish between zoonotic and sustained human outbreaks and help accurately inform public health responses.
- 10 December 2025
- Published by Oxford University Press (OUP) in Virus Evolution
- Vol. 12 (1)
Open AccessHuman outbreak detection and best practice MPXV analysis and interpretation with squirrel
High numbers of reported mpox cases and recent identification of multiple sustained human outbreaks of mpox virus (MPXV) have highlighted the need for robust, best-practice genomic surveillance tools. In light of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, many labs across the globe developed the capacity to do virus genome sequencing; however, MPXV presents additional analytical challenges due to its large genome size, tracts of low-complexity or repeat regions, genetically distinct clades, and the need to perform bespoke apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3 (APOBEC3)-mutation reconstruction. We present squirrel (Some Quick Reconstruction to Resolve Evolutionary Links), an open source bioinformatic tool that can perform clade-aware alignment, mutation quality assessment, phylogenetic inference, and automated APOBEC3-mutation classification on branches of the phylogeny. Squirrel can be run on the command line or launched through the EPI2ME graphical user interface through the squirrel-nf workflow, enabling robust analysis without need for the command line. With the interactive output report produced and publication-ready APOBEC3-reconstruction visualization, squirrel enables researchers to distinguish between zoonotic and sustained human outbreaks and help accurately inform public health responses.
- Open Access
- 14 October 2024
- Published by Microbiology Society in Microbial Genomics
- Vol. 10 (10) , 001293
The Canadian VirusSeq Data Portal and Duotang: open resources for SARS-CoV-2 viral sequences and genomic epidemiology
The COVID-19 pandemic led to a large global effort to sequence SARS-CoV-2 genomes from patient samples to track viral evolution and inform the public health response. Millions of SARS-CoV-2 genome sequences have been deposited in global public repositories. The Canadian COVID-19 Genomics Network (CanCOGeN – VirusSeq), a consortium tasked with coordinating expanded sequencing of SARS-CoV-2 genomes across Canada early in the pandemic, created the Canadian VirusSeq Data Portal, with associated data pipelines and procedures, to support these efforts. The goal of VirusSeq was to allow open access to Canadian SARS-CoV-2 genomic sequences and enhanced, standardized contextual data that were unavailable in other repositories and that meet FAIR standards (Findable, Accessible, Interoperable and Reusable). In addition, the portal data submission pipeline contains data quality checking procedures and appropriate acknowledgement of data generators that encourages collaboration. From inception to execution, the portal was developed with a conscientious focus on strong data governance principles and practices. Extensive efforts ensured a commitment to Canadian privacy laws, data security standards, and organizational processes. This portal has been coupled with other resources, such as Viral AI, and was further leveraged by the Coronavirus Variants Rapid Response Network (CoVaRR-Net) to produce a suite of continually updated analytical tools and notebooks. Here we highlight this portal (https://virusseq-dataportal.ca/), including its contextual data not available elsewhere, and the Duotang (https://covarr-net.github.io/duotang/duotang.html), a web platform that presents key genomic epidemiology and modelling analyses on circulating and emerging SARS-CoV-2 variants in Canada. Duotang presents dynamic changes in variant composition of SARS-CoV-2 in Canada and by province, estimates variant growth, and displays complementary interactive visualizations, with a text overview of the current situation. The VirusSeq Data Portal and Duotang resources, alongside additional analyses and resources computed from the portal (COVID-MVP, CoVizu), are all open source and freely available. Together, they provide an updated picture of SARS-CoV-2 evolution to spur scientific discussions, inform public discourse, and support communication with and within public health authorities. They also serve as a framework for other jurisdictions interested in open, collaborative sequence data sharing and analyses.
- 14 October 2024
- Published by Microbiology Society in Microbial Genomics
- Vol. 10 (10) , 001293
Open AccessThe Canadian VirusSeq Data Portal and Duotang: open resources for SARS-CoV-2 viral sequences and genomic epidemiology
The COVID-19 pandemic led to a large global effort to sequence SARS-CoV-2 genomes from patient samples to track viral evolution and inform the public health response. Millions of SARS-CoV-2 genome sequences have been deposited in global public repositories. The Canadian COVID-19 Genomics Network (CanCOGeN – VirusSeq), a consortium tasked with coordinating expanded sequencing of SARS-CoV-2 genomes across Canada early in the pandemic, created the Canadian VirusSeq Data Portal, with associated data pipelines and procedures, to support these efforts. The goal of VirusSeq was to allow open access to Canadian SARS-CoV-2 genomic sequences and enhanced, standardized contextual data that were unavailable in other repositories and that meet FAIR standards (Findable, Accessible, Interoperable and Reusable). In addition, the portal data submission pipeline contains data quality checking procedures and appropriate acknowledgement of data generators that encourages collaboration. From inception to execution, the portal was developed with a conscientious focus on strong data governance principles and practices. Extensive efforts ensured a commitment to Canadian privacy laws, data security standards, and organizational processes. This portal has been coupled with other resources, such as Viral AI, and was further leveraged by the Coronavirus Variants Rapid Response Network (CoVaRR-Net) to produce a suite of continually updated analytical tools and notebooks. Here we highlight this portal (https://virusseq-dataportal.ca/), including its contextual data not available elsewhere, and the Duotang (https://covarr-net.github.io/duotang/duotang.html), a web platform that presents key genomic epidemiology and modelling analyses on circulating and emerging SARS-CoV-2 variants in Canada. Duotang presents dynamic changes in variant composition of SARS-CoV-2 in Canada and by province, estimates variant growth, and displays complementary interactive visualizations, with a text overview of the current situation. The VirusSeq Data Portal and Duotang resources, alongside additional analyses and resources computed from the portal (COVID-MVP, CoVizu), are all open source and freely available. Together, they provide an updated picture of SARS-CoV-2 evolution to spur scientific discussions, inform public discourse, and support communication with and within public health authorities. They also serve as a framework for other jurisdictions interested in open, collaborative sequence data sharing and analyses.
- Open Access
- 19 August 2024
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 20 (8) , e1011539
In silico analyses identify sequence contamination thresholds for Nanopore-generated SARS-CoV-2 sequences
The SARS-CoV-2 pandemic has brought molecular biology and genomic sequencing into the public consciousness and lexicon. With an emphasis on rapid turnaround, genomic data informed both diagnostic and surveillance decisions for the current pandemic at a previously unheard-of scale. The surge in the submission of genomic data to publicly available databases proved essential as comparing different genome sequences offers a wealth of knowledge, including phylogenetic links, modes of transmission, rates of evolution, and the impact of mutations on infection and disease severity. However, the scale of the pandemic has meant that sequencing runs are rarely repeated due to limited sample material and/or the availability of sequencing resources, resulting in the upload of some imperfect runs to public repositories. As a result, it is crucial to investigate the data obtained from these imperfect runs to determine whether the results are reliable prior to depositing them in a public database. Numerous studies have identified a variety of sources of contamination in public next-generation sequencing (NGS) data as the number of NGS studies increases along with the diversity of sequencing technologies and procedures. For this study, we conducted an in silico experiment with known SARS-CoV-2 sequences produced from Oxford Nanopore Technologies sequencing to investigate the effect of contamination on lineage calls and single nucleotide variants (SNVs). A contamination threshold below which runs are expected to generate accurate lineage calls and maintain genome-relatedness and integrity was identified. Together, these findings provide a benchmark below which imperfect runs may be considered robust for reporting results to both stakeholders and public repositories and reduce the need for repeat or wasted runs.
- 19 August 2024
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 20 (8) , e1011539
Open AccessIn silico analyses identify sequence contamination thresholds for Nanopore-generated SARS-CoV-2 sequences
The SARS-CoV-2 pandemic has brought molecular biology and genomic sequencing into the public consciousness and lexicon. With an emphasis on rapid turnaround, genomic data informed both diagnostic and surveillance decisions for the current pandemic at a previously unheard-of scale. The surge in the submission of genomic data to publicly available databases proved essential as comparing different genome sequences offers a wealth of knowledge, including phylogenetic links, modes of transmission, rates of evolution, and the impact of mutations on infection and disease severity. However, the scale of the pandemic has meant that sequencing runs are rarely repeated due to limited sample material and/or the availability of sequencing resources, resulting in the upload of some imperfect runs to public repositories. As a result, it is crucial to investigate the data obtained from these imperfect runs to determine whether the results are reliable prior to depositing them in a public database. Numerous studies have identified a variety of sources of contamination in public next-generation sequencing (NGS) data as the number of NGS studies increases along with the diversity of sequencing technologies and procedures. For this study, we conducted an in silico experiment with known SARS-CoV-2 sequences produced from Oxford Nanopore Technologies sequencing to investigate the effect of contamination on lineage calls and single nucleotide variants (SNVs). A contamination threshold below which runs are expected to generate accurate lineage calls and maintain genome-relatedness and integrity was identified. Together, these findings provide a benchmark below which imperfect runs may be considered robust for reporting results to both stakeholders and public repositories and reduce the need for repeat or wasted runs.
- Open Access
In silico analyses identifies sequence contamination thresholds for Nanopore-generated SARS-CoV2 sequences
The SARS-CoV-2 pandemic has brought molecular biology and genomic sequencing into the public consciousness and lexicon. With an emphasis on rapid turnaround, genomic data has been used to inform both diagnostic and surveillance decisions for the current pa ndemic at a previously unheard-of scale. The surge in the submission of genomic data to publicly-available databases has proved essential as comparing different genome sequences offers a wealth of knowledge, including phylogenetic links, modes of transmission, rates of evolution, and the impact of mutations on infection and disease severity. However, the scale of the pandemic has meant that once sequencing runs are performed, they are rarely repeated due to limited sample material and/or the availability of sequencing resources, resulting in some imperfect runs being uploaded to public repositories. As a result, it is crucial to investigate the data obtained from these imperfect runs to determine whether the results are reliable. Numerous studies have identified a variety of sources of contamination in public next-generation sequencing (NGS) data as the number of NGS studies increases along with the diversity of sequencing technologies and procedures [1–3]. For this study, we conducted an in silico experiment with known SARS-CoV-2 sequences produced from Oxford Nanopore Technologies sequencing to investigate the effect of contamination on lineage calls and single nucleotide variations (SNVs). Through a series of analyses, we identified a contamination threshold below which runs are expected to generate accurate lineage calls and maintain genomic sequence integrity. Together, these findings provide a benchmark below which imperfect runs may be considered robust for reporting results to both stakeholders and public repositories and reduce the need for repeat or wasted runs. Author Summary: Large-scale genomic comparisons provide a wealth of knowledge, including modes of transmission, rates of evolution, and the impact of mutations on infection, disease severity, and treatment effectiveness. As a result, the public release of genomic data has proven to be crucial. However, studies continue to show that some of the genomic data in public repositories are contaminated due to a variety of reasons. For instance, in the case of SARS-CoV-2 sequences, the pandemic prevented many sequencing runs from being repeated, resulting in some imperfect runs being uploaded to public repositories. It is of note that when genomic data is contaminated, both scientific decisions/studies and public health measures may be compromised. To identify genome contamination threshold(s) for SARS-CoV-2 sequences generated by Nanopore sequencing, computational biology techniques were utilized to generate artificially subsampled contaminated genomes. This is the first study of its kind and so our hope is that the results obtained provide a starting point for the investigation of reporting contamination of NGS data.
Open AccessIn silico analyses identifies sequence contamination thresholds for Nanopore-generated SARS-CoV2 sequences
The SARS-CoV-2 pandemic has brought molecular biology and genomic sequencing into the public consciousness and lexicon. With an emphasis on rapid turnaround, genomic data has been used to inform both diagnostic and surveillance decisions for the current pa ndemic at a previously unheard-of scale. The surge in the submission of genomic data to publicly-available databases has proved essential as comparing different genome sequences offers a wealth of knowledge, including phylogenetic links, modes of transmission, rates of evolution, and the impact of mutations on infection and disease severity. However, the scale of the pandemic has meant that once sequencing runs are performed, they are rarely repeated due to limited sample material and/or the availability of sequencing resources, resulting in some imperfect runs being uploaded to public repositories. As a result, it is crucial to investigate the data obtained from these imperfect runs to determine whether the results are reliable. Numerous studies have identified a variety of sources of contamination in public next-generation sequencing (NGS) data as the number of NGS studies increases along with the diversity of sequencing technologies and procedures [1–3]. For this study, we conducted an in silico experiment with known SARS-CoV-2 sequences produced from Oxford Nanopore Technologies sequencing to investigate the effect of contamination on lineage calls and single nucleotide variations (SNVs). Through a series of analyses, we identified a contamination threshold below which runs are expected to generate accurate lineage calls and maintain genomic sequence integrity. Together, these findings provide a benchmark below which imperfect runs may be considered robust for reporting results to both stakeholders and public repositories and reduce the need for repeat or wasted runs. Author Summary: Large-scale genomic comparisons provide a wealth of knowledge, including modes of transmission, rates of evolution, and the impact of mutations on infection, disease severity, and treatment effectiveness. As a result, the public release of genomic data has proven to be crucial. However, studies continue to show that some of the genomic data in public repositories are contaminated due to a variety of reasons. For instance, in the case of SARS-CoV-2 sequences, the pandemic prevented many sequencing runs from being repeated, resulting in some imperfect runs being uploaded to public repositories. It is of note that when genomic data is contaminated, both scientific decisions/studies and public health measures may be compromised. To identify genome contamination threshold(s) for SARS-CoV-2 sequences generated by Nanopore sequencing, computational biology techniques were utilized to generate artificially subsampled contaminated genomes. This is the first study of its kind and so our hope is that the results obtained provide a starting point for the investigation of reporting contamination of NGS data.
- Open Access
- 6 September 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-15
Ancient Clostridium DNA and variants of tetanus neurotoxins associated with human archaeological remains
The analysis of microbial genomes from human archaeological samples offers a historic snapshot of ancient pathogens and provides insights into the origins of modern infectious diseases. Here, we analyze metagenomic datasets from 38 human archaeological samples and identify bacterial genomic sequences related to modern-day Clostridium tetani, which produces the tetanus neurotoxin (TeNT) and causes the disease tetanus. These genomic assemblies had varying levels of completeness, and a subset of them displayed hallmarks of ancient DNA damage. Phylogenetic analyses revealed known C. tetani clades as well as potentially new Clostridium lineages closely related to C. tetani. The genomic assemblies encode 13 TeNT variants with unique substitution profiles, including a subgroup of TeNT variants found exclusively in ancient samples from South America. We experimentally tested a TeNT variant selected from an ancient Chilean mummy sample and found that it induced tetanus muscle paralysis in mice, with potency comparable to modern TeNT. Thus, our ancient DNA analysis identifies DNA from neurotoxigenic C. tetani in archaeological human samples, and a novel variant of TeNT that can cause disease in mammals.
- 6 September 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-15
Open AccessAncient Clostridium DNA and variants of tetanus neurotoxins associated with human archaeological remains
The analysis of microbial genomes from human archaeological samples offers a historic snapshot of ancient pathogens and provides insights into the origins of modern infectious diseases. Here, we analyze metagenomic datasets from 38 human archaeological samples and identify bacterial genomic sequences related to modern-day Clostridium tetani, which produces the tetanus neurotoxin (TeNT) and causes the disease tetanus. These genomic assemblies had varying levels of completeness, and a subset of them displayed hallmarks of ancient DNA damage. Phylogenetic analyses revealed known C. tetani clades as well as potentially new Clostridium lineages closely related to C. tetani. The genomic assemblies encode 13 TeNT variants with unique substitution profiles, including a subgroup of TeNT variants found exclusively in ancient samples from South America. We experimentally tested a TeNT variant selected from an ancient Chilean mummy sample and found that it induced tetanus muscle paralysis in mice, with potency comparable to modern TeNT. Thus, our ancient DNA analysis identifies DNA from neurotoxigenic C. tetani in archaeological human samples, and a novel variant of TeNT that can cause disease in mammals.
- 29 August 2023
- Published by Peer Community In in Peer Community Journal
- Vol. 3
Genomic data suggest parallel dental vestigialization within the xenarthran radiation
The recent influx of genomic data has provided greater insights into the molecular basis for regressive evolution, or vestigialization, through gene loss and pseudogenization. As such, the analysis of gene degradation patterns has the potential to provide insights into the evolutionary history of regressed anatomical traits. We specifically applied these principles to the xenarthran radiation (anteaters, sloths, armadillos), which is characterized by taxa with a gradation in regressed dental phenotypes. Whether the pattern among extant xenarthrans is due to an ancient and gradual decay of dental morphology or occurred repeatedly in parallel is unknown. We tested these competing hypotheses by examining 11 core dental genes in most living species of Xenarthra, characterizing shared inactivating mutations and patterns of relaxed selection during their radiation. Here we report evidence of independent and distinct events of dental gene loss in the major xenarthran subclades. First, we found strong evidence of complete enamel loss in the common ancestor of sloths and anteaters, suggested by the inactivation of five enamel-associated genes (AMELX, AMTN, MMP20, ENAM, ACP4). Next, whereas dental regression appears to have halted in sloths, presumably a critical event that ultimately permitted adaptation to an herbivorous lifestyle, anteaters continued losing genes on the path towards complete tooth loss. Echoes of this event are recorded in the genomes of all living anteaters, being marked by a 2-bp deletion in a gene critical for dentinogenesis (DSPP) and a putative shared 1-bp insertion in a gene linked to tooth retention (ODAPH). By contrast, in the two major armadillo clades, genes pertaining to the dento-gingival junction and amelogenesis appear to have been independently inactivated prior to losing all or some enamel. These genomic data provide evidence for multiple pathways and rates of anatomical regression, and underscore the utility of using pseudogenes to reconstruct evolutionary history when fossils are sparse.
- 29 August 2023
- Published by Peer Community In in Peer Community Journal
- Vol. 3
Genomic data suggest parallel dental vestigialization within the xenarthran radiation
The recent influx of genomic data has provided greater insights into the molecular basis for regressive evolution, or vestigialization, through gene loss and pseudogenization. As such, the analysis of gene degradation patterns has the potential to provide insights into the evolutionary history of regressed anatomical traits. We specifically applied these principles to the xenarthran radiation (anteaters, sloths, armadillos), which is characterized by taxa with a gradation in regressed dental phenotypes. Whether the pattern among extant xenarthrans is due to an ancient and gradual decay of dental morphology or occurred repeatedly in parallel is unknown. We tested these competing hypotheses by examining 11 core dental genes in most living species of Xenarthra, characterizing shared inactivating mutations and patterns of relaxed selection during their radiation. Here we report evidence of independent and distinct events of dental gene loss in the major xenarthran subclades. First, we found strong evidence of complete enamel loss in the common ancestor of sloths and anteaters, suggested by the inactivation of five enamel-associated genes (AMELX, AMTN, MMP20, ENAM, ACP4). Next, whereas dental regression appears to have halted in sloths, presumably a critical event that ultimately permitted adaptation to an herbivorous lifestyle, anteaters continued losing genes on the path towards complete tooth loss. Echoes of this event are recorded in the genomes of all living anteaters, being marked by a 2-bp deletion in a gene critical for dentinogenesis (DSPP) and a putative shared 1-bp insertion in a gene linked to tooth retention (ODAPH). By contrast, in the two major armadillo clades, genes pertaining to the dento-gingival junction and amelogenesis appear to have been independently inactivated prior to losing all or some enamel. These genomic data provide evidence for multiple pathways and rates of anatomical regression, and underscore the utility of using pseudogenes to reconstruct evolutionary history when fossils are sparse.
- Open Access
- 1 January 2023
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 176 (1) , 67-76
Monkeypox in Montréal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak
A global outbreak of monkeypox occurred beginning in mid-2022 outside of endemic areas. This report characterizes the outbreak of monkeypox in Montréal, the first large outbreak in North America, u... Visual Monkeypox in Montréal. A global outbreak of monkeypox occurred beginning in mid-2022 outside of endemic areas. This report characterizes the outbreak of monkeypox in Montréal, the f... Background: Monkeypox, a viral zoonotic disease, is causing a global outbreak outside of endemic areas. Objective: To characterize the outbreak of monkeypox in Montréal, the first large outbreak in...
- 1 January 2023
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 176 (1) , 67-76
Open AccessMonkeypox in Montréal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak
A global outbreak of monkeypox occurred beginning in mid-2022 outside of endemic areas. This report characterizes the outbreak of monkeypox in Montréal, the first large outbreak in North America, u... Visual Monkeypox in Montréal. A global outbreak of monkeypox occurred beginning in mid-2022 outside of endemic areas. This report characterizes the outbreak of monkeypox in Montréal, the f... Background: Monkeypox, a viral zoonotic disease, is causing a global outbreak outside of endemic areas. Objective: To characterize the outbreak of monkeypox in Montréal, the first large outbreak in...